Close Menu

NEW YORK – Finnish diagnostics firm Nightingale Health said Wednesday that it has closed an €8.8 million ($10.7 million) funding round.

The company said that the funding will strengthen its working capital as it investigates the possibility of listing its shares on the Nasdaq First North Growth Market.

Finnish private investors contributed to the round including Timo Soininen, the chairman of Nightingale's board; Markku Kaloniemi; Mikko Kodisoja; the Langenskiöld family investment firm; and Leena Niemistö.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.